Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report

Elizabete Pumpure; Eva Dručka; Dana Kigitoviča; Raimundas Meškauskas; Sergejs Isajevs; Ineta Nemiro; Agnija Rasa; Evija Olmane; Tatjana Zablocka; Pēteris Alberts; Simona Doniņa

doi:10.1002/ccr3.2928

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report

Elizabete Pumpure, Eva Dručka, Dana Kigitoviča, Raimundas Meškauskas, Sergejs Isajevs, Ineta Nemiro, Agnija Rasa (Corresponding Author), Evija Olmane, Tatjana Zablocka, Pēteris Alberts, Simona Doniņa

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir^® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.

Original language	English
Pages (from-to)	1538-1543
Number of pages	6
Journal	Clinical Case Reports
Volume	8
Issue number	8
DOIs	https://doi.org/10.1002/ccr3.2928
Publication status	Published - 1 Aug 2020

Keywords*

ECHO-7 virus
melanoma
oncology
oncolytic virus
Rigvir
uterine cervix

Field of Science*

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.1002/ccr3.2928

Cite this

Pumpure, E., Dručka, E., Kigitoviča, D., Meškauskas, R., Isajevs, S., Nemiro, I., Rasa, A., Olmane, E., Zablocka, T., Alberts, P., & Doniņa, S. (2020). Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report. Clinical Case Reports, 8(8), 1538-1543. https://doi.org/10.1002/ccr3.2928

@article{107c962a6a4f4fc8bc5c22988f563834,

title = "Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report",

abstract = "Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir{\textregistered} as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.",

keywords = "ECHO-7 virus, melanoma, oncology, oncolytic virus, Rigvir, uterine cervix",

author = "Elizabete Pumpure and Eva Dru{\v c}ka and Dana Kigitovi{\v c}a and Raimundas Me{\v s}kauskas and Sergejs Isajevs and Ineta Nemiro and Agnija Rasa and Evija Olmane and Tatjana Zablocka and Pēteris Alberts and Simona Doniņa",

year = "2020",

month = aug,

day = "1",

doi = "10.1002/ccr3.2928",

language = "English",

volume = "8",

pages = "1538--1543",

journal = "Clinical Case Reports",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

Pumpure, E , Dručka, E , Kigitoviča, D, Meškauskas, R, Isajevs, S, Nemiro, I, Rasa, A, Olmane, E, Zablocka, T, Alberts, P & Doniņa, S 2020, 'Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report', Clinical Case Reports, vol. 8, no. 8, pp. 1538-1543. https://doi.org/10.1002/ccr3.2928

TY - JOUR

T1 - Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy

T2 - A case report

AU - Pumpure, Elizabete

AU - Dručka, Eva

AU - Kigitoviča, Dana

AU - Meškauskas, Raimundas

AU - Isajevs, Sergejs

AU - Nemiro, Ineta

AU - Rasa, Agnija

AU - Olmane, Evija

AU - Zablocka, Tatjana

AU - Alberts, Pēteris

AU - Doniņa, Simona

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.

AB - Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.

KW - ECHO-7 virus

KW - melanoma

KW - oncology

KW - oncolytic virus

KW - Rigvir

KW - uterine cervix

UR - http://www.scopus.com/inward/record.url?scp=85085024392&partnerID=8YFLogxK

U2 - 10.1002/ccr3.2928

DO - 10.1002/ccr3.2928

M3 - Article

AN - SCOPUS:85085024392

VL - 8

SP - 1538

EP - 1543

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 8

ER -

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report

Abstract

Keywords*

Field of Science*

Publication Type*

Access to Document

Other files and links

Fingerprint

Cite this